EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Current Progress in Kidney Xenotransplantation: Time to Proceed to Clinical Trials

Takayuki Hirose iD, Kiyohiko Hotta iD, Tatsuo Kawai iD

International Journal of Urology · 2025

DOI: 10.1111/iju.70173 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Urology, 2025. Verfasst von Takayuki Hirose und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hokkaido University Hospital, Sapporo, Japan. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Kidney Transplantation, Graft Rejection, Kidney Failure, Chronic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney transplantation is the ideal treatment for end‐stage kidney disease, but the shortage of donors limits its clinical implementation. Although xenotransplantation, particularly from pigs, is a promising approach to address the donor shortage, significant challenges, such as immune rejection and disease transmission, exist. However, recent advances in gene‐editing technology as well as development of novel immunosuppressive drugs have significantly improved xenotransplant outcomes in nonhuman primates. Recent studies on xenotransplantation using decedent recipients have provided novel insights into human immune responses to porcine xenografts, despite the limited observation time in these recipients. Building upon these preclinical studies, four cases of clinical kidney xenotransplantation have recently been performed under a “expanded access authorization.” Understanding immunological responses, as well as various physiological discrepancies between human and porcine kidney function, must be enhanced before xenotransplantation can become a viable clinical solution to organ shortages. This review summarizes the current progress of kidney xenotransplantation in nonhuman primate models, decedent models, and clinical cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation, HeterologousKidney TransplantationGraft RejectionKidney Failure, ChronicAnimalsHumansSwineClinical Trials as TopicGraft SurvivalImmunosuppressive AgentsHeterograftsPrimates

Stichwörter der Autor:innen

CRISPR/Cas9gene‐edited pigkidney transplantationxenotransplantation

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Urology, Hokkaido University Hospital, Sapporo, Japan.
  • Massachusetts General Hospital, Department of Surgery, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Takayuki Hirose, Kiyohiko Hotta, Tatsuo Kawai

Zitieren

APA

Hirose, T., Hotta, K., & Kawai, T. (2025). Current Progress in Kidney Xenotransplantation: Time to Proceed to Clinical Trials. International Journal of Urology. https://doi.org/10.1111/iju.70173

Vancouver

Hirose T, Hotta K, Kawai T. Current Progress in Kidney Xenotransplantation: Time to Proceed to Clinical Trials. International Journal of Urology. 2025. doi:10.1111/iju.70173

BibTeX
@article{Hirose2025,
  author = {Hirose, Takayuki and Hotta, Kiyohiko and Kawai, Tatsuo},
  title = {Current Progress in Kidney Xenotransplantation: Time to Proceed to Clinical Trials},
  journal = {International Journal of Urology},
  year = {2025},
  doi = {10.1111/iju.70173}
}
Kostenlos starten →